Standout Papers

A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemot... 2008 2026 2014 2020 629
  1. A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer (2008)
    J. Randolph Hecht, Edith P. Mitchell et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 5 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
4 intermediate papers

Works of Seta Shahin being referenced

A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
2008 Standout

Author Peers

Author Last Decade Papers Cites
Seta Shahin 794 315 95 183 13 925
E. Magherini 770 252 46 118 24 1.0k
Laurent Bastit 633 340 83 100 19 1.1k
Tracy Proverbs‐Singh 673 262 48 67 14 1.1k
Nicola Borsellino 689 322 30 221 19 855
A. Misino 735 357 25 217 25 955
Mark Gimbel 661 154 79 164 17 1.0k
Hiroomi Tada 527 390 57 103 13 936
В. С. Медведев 393 240 116 66 11 925
John Frye 284 173 50 148 24 744
Yong-Qiang Li 669 104 40 138 24 1.1k

All Works

Loading papers...

Rankless by CCL
2026